[Fundamental properties of the BK-Kharkov" vaccinal strain of Mycobacterium tuberculosis].
作者信息
Dikiĭ I L
出版信息
Mikrobiol Zh (1978). 1982 Jul-Aug;44(4):48-51.
PMID:6813655
Abstract
摘要
相似文献
1
[Fundamental properties of the BK-Kharkov" vaccinal strain of Mycobacterium tuberculosis].[结核分枝杆菌“哈尔科夫BK”疫苗株的基本特性]
Mikrobiol Zh (1978). 1982 Jul-Aug;44(4):48-51.
2
[Immunological properties of attenuated tuberculosis strain "BK-Kharkov". I. The comparative characteristics of the structural lipids and their relationship to the immunogenic properties of the "BK-Kharkov" and BCG strains].减毒结核菌株“BK - 哈尔科夫”的免疫学特性。I. “BK - 哈尔科夫”和卡介苗菌株结构脂质的比较特征及其与免疫原性的关系
Mikrobiol Zh. 1976;38(3):325-30.
3
[Mechanism of action of ectericide on Mycobacterium tuberculosis].
Probl Tuberk. 1984 Mar(3):60-4.
4
[New tuberculosis vaccine: dream or reality?].[新型结核病疫苗：梦想还是现实？]
Probl Tuberk. 2001(1):53-5.
5
Current tuberculosis vaccine development.当前结核病疫苗的研发
Clin Infect Dis. 2000 Jun;30 Suppl 3:S254-6. doi: 10.1086/313871.
6
Recombinant Mycobacterium bovis BCG.重组牛分枝杆菌卡介苗
Vaccine. 2009 Nov 5;27(47):6495-503. doi: 10.1016/j.vaccine.2009.08.044. Epub 2009 Aug 29.
7
The use of mutant mycobacteria as new vaccines to prevent tuberculosis.使用突变分枝杆菌作为预防结核病的新型疫苗。
Tuberculosis (Edinb). 2006 May-Jul;86(3-4):203-10. doi: 10.1016/j.tube.2006.01.022. Epub 2006 Mar 20.
8
Advances in tuberculosis vaccine strategies.结核病疫苗策略的进展
Nat Rev Microbiol. 2006 Jun;4(6):469-76. doi: 10.1038/nrmicro1419.
9
Animal models for experimental tuberculosis.
Clin Infect Dis. 2000 Sep;31 Suppl 3:S68-70. doi: 10.1086/314071.
10
Susceptibility testing of the live attenuated tuberculosis vaccine BCG and the vaccine candidate MTBVAC to currently WHO-recommended anti-tuberculosis drugs by the European committee on antimicrobial susceptibility testing (EUCAST) method.采用欧洲抗菌药物敏感性试验委员会（EUCAST）方法，对减毒活结核疫苗卡介苗（BCG）和候选疫苗MTBVAC进行针对目前世界卫生组织推荐的抗结核药物的敏感性试验。
Clin Microbiol Infect. 2024 Aug;30(8):1080-1082. doi: 10.1016/j.cmi.2024.04.017. Epub 2024 May 7.
Zotero 插件